Your A-Z of episodes

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam is a Managing Director and Partner in L.E.K. Consulting’s New York …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stephen Dilly, Chairman, President and Chief Executive Officer at Codexis. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Stephen, covering: As President & CEO of Codexis since August 2022, Stephen brings …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tara Dougal, Event Director – Pharma (CPHI Europe). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tara, covering: Tara brings over 12 years of extensive event management experience spanning roles in …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Riches, Vice President, Clinical Solutions at Citeline. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: With over 30 years’ experience in the life science sector, Claire is a …

Boston’s Dr. Andrea N. Wagner, CEO at PharmaPhixx, shares her journey in sterile manufacturing, entrepreneurship, and empowering women in STEM.

Explore India’s evolving pharma landscape with Ankit Gupta, CEO at Tenshi Kaizen, as he shares insights on drug delivery innovation, CDMO growth, and strategic leadership in biopharma.

Explore the journey of Adam Sherlock, CEO at Qinecsa, as he shares insights on M&A, leadership, and the future of R&D.

Panel insights from CDMO Live 2025: Experts discuss funding strain, pricing shifts, global trade impact, and future-proofing strategies for pharma outsourcing.

Join Immunic CSO Dr. Hella Kohlhof as she shares biotech insights on global outsourcing, Nasdaq growth, and scientific leadership.

Explore how Dr. Tim Showalter, Radiation Oncologist and CMO at ArteraAI, is transforming prostate cancer care with AI-powered diagnostics.